chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (The liquid dripped down the arm and the needle stabbed into the arm.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (The liquid dripped down the arm and the needle stabbed into the arm.). On 22-Feb-2021, ACCIDENTAL EXPOSURE TO PRODUCT (The liquid dripped down the arm and the needle stabbed into the arm.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided No treatment medication was provided
when I go to the bathroom, I have blood coming out; This is a spontaneous report from a contactable consumer (patient). A 44-year-old patient of an unspecified gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, Lot Number: EW0172), via an unspecified route of administration, administered in the right deltoid (also reported as right shoulder) on 04May2021 as an unknown dose number, as a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported.  After the patient had the vaccine, ever since an unspecified date, the patient reported 'when I go to the bathroom, I have blood coming out'. The patient has not taken any treatment for the event. The outcome of the event was unknown.
ED visit within 1 month after first COVID shot - felt lightheaded this am and has been sleeping much more than usual since his COVID shot. Yesterday and this am lightheaded.  "Felt like wall moving", nausea and emesis twice and ongoing nausea.
High Levels of ALT (SGPT) at 65 on 7/03/2021, the Last result was on 06/29/2019 ALT (SGPT) at 20
Pt was given the influenza Adjuvanted (FLUAD) vaccine instead of the regular Influenza vaccine. Pt was fine no adverse reaction tolerated fine. Notified Provider FNP of the error. Provider noted that is okay no additional orders needed. F/u with Patient on 2/22/2018 pt notified of the error and pt stated she is fine no problems.
After both of my Pfizer vaccinations, I had heart palpitations, PVCs, tachycardia for several weeks after both of them. I wore a heart monitor that confirmed.
C/O numbness around lips, able to stick tongue out and move, no discoloration  around lips, able to talk without difficulty,  pt states at  13:15BP 150/90 Hr 71 Spo2 100,  13:30 BP 154/105, HR 74 Spo2 100  13:35 that she feels anxious and will take her anti anxiety meds at home.   instructed to F/U with PCP.
Pt stated that he woke up the next morning with  ringing in his R ear  the day after the 2d vaccine.  He stated that  he is still having ringing in his ear today.
About 15 min after ZOSTAVAC admin pt said she didn't "feel right" her mouth was tingling all around it, her throat felt tight & she was dizzy. Took BP 164/79 pulse 110 called 911 gave 0.3mg Epi. Took BP 150/77 pulse 103 pt left in ambulance.
redness and swelling and itching at the shot site. It did not show up until 4 days after I had the shot. I am taking Naproxen Sodium 2x a day. I'm not running a fever or feeling bad. just tenderness and swelling at the site. The muscle feels thick around the site.
I first felt swelling and burning in my left arm the next day. On Saturday 11/9/02, I experienced severe nausea, vomiting and diarrhea till 11/16/02. I also had hives, dizziness and weakness. I went to my doctor and they stated I had a reaction to the flu shot and that I was dehydrated. I also had a high temperature. On 11/22/02 I was take to the ER with the same symptoms. The ER took blood work. Again I was told I was dehydrated. I needed two IVs and Phenaphen at the ER on 11/22/02. I was sick for 16 days.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. No information was provide regarding the patient's concomitant medications, pertinent medical history, drug reactions and allergies. On 04-JAN-2019, the patient was vaccinated with a dose of PROQUAD, therapy type: recombinant human albumin (rHA), lot # R013126 with the expiration date of 04-NOV-2019 (exact dose and dose number were not reported), via intramuscular route for prophylaxis. The vaccine was reconstituted with sterile diluent (lot# R001254, expiration date 20-SEP-2020). No adverse effects were reported.
Severe swelling of the arm, red all the way to his elbow. Night sweats, headache, wheezing, not sleeping. Still has severe red awollen arm to elbow.
No adverse reaction to Moderna vaccine. Patient was under the recommended age to obtain vaccine as Pfizer is the only approved vaccine for that age range. When verifying CDC they still recommend to provide second dosage for child if first dose was administered.
Significant pain at injection site after both shots. Pain persisted and remains now 3 months post 2 shot.  Unable to lift  left are without significant pain. Ability to work has been impaired as well as sleep.  Can?t sleep on left side of body, lift arm to dress, grab seatbelt to drive, use left arm to lift or move body.  Unable to cross my left arm across body  beyond right shoulderOften, the pain radiates beyond upper arm and aches through the wrist.  I am on constant pain,  OTC anti-inflammatory  DOES NOT HELP nor does ice or heat.  Nothing has helped
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX (batch number CH2X7, expiry date 25th April 2020) for prophylaxis. On 16th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, 7 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that a patient developed shingles about one week after receipt of SHINGRIX.
Chills, coughing, headache, muscle aches, fatigue, tightness in chest, skin tenderness.
After my second dose I started to feel under my right arm pain and my lymph nodes got swollen. I went to see my PCP and a CT scan of the right upper extremity was ordered. My CT scan diagnosis was lymphadenopathy. They then performed an U/S guided biopsy of my right upper extremity which was inconclusive. Since my report was  inconclusive, I now have to get a repeat biopsy and I am scheduled for 04-01-2021.  On 03-31-2021, I was also be going in for a marker place to demonstrate area concern for further diagnosis.
10/21/21  The patient is a 64 yr/o female with a history of CKD, HLD, HTN, osteoporosis, cancer, right kidney transplant presents with multiple complaints. She reports that she's had subjective fever, RLQ pain, cough, and fatigue over the past 13 days. She reports that she saw her nephrologist on 10/8/21, had labs done, got a flu shot, and has since developed her symptoms after that appointment. She reports that she feels fine during the day, however at night she is fatigued, develops a low grade fever with chills, muscle aches, headaches, nausea, and night sweats. She also reports decreased urinary frequency and urinary "pressure", and that she is concerned for possible UTI. Sent from clinic  10/21-10/23/21 Hospitalized:  Admission Review of Systems Review of Systems  Constitutional: Positive for diaphoresis, fatigue and fever. Negative for chills.       Fever is subjective  HENT: Negative for nosebleeds, sneezing, voice change and ear discharge.   Eyes: Negative for discharge and redness.  Respiratory: Positive for cough. Negative for chest tightness, shortness of breath and wheezing.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Negative for abdominal distention, abdominal pain, constipation, diarrhea, nausea and vomiting.  Genitourinary: Negative for difficulty urinating, dysuria and urgency.       Decreased urinary frequency, notes "pressure" with urination  Musculoskeletal:       Generalized muscle aches  Skin: Negative for rash and wound.  Neurological: Positive for headaches. Negative for dizziness, speech difficulty and weakness.  All other systems reviewed and are negative.   10/23/21 Discharge summary:   Patient was admitted to NAH with acute complaint of fevers and feeling poorly she has history of recurrent UTI and was noted to have +UA and was started on IV rocephin. She was also noted to be COVID19 + on rapid test, but was asymptomatic. She had previously been treated for COVID19 2 months ago. She is on RA and feeling okay from that standpoint. She was treated with IV abx, given history of renal transplant Nephrology was consulted and patient was resumed on home immunosuppressives. Renal function has been stable. Renal consulted and agreeable for discharge home. Patient doing well and no more fevers. She no longer meets sepsis criteria urine culure was negative. She will need to complete 5 more days of ciprofloxacin on discharge. Patient is agreeable for this. Urology was also consulted given recurrent UTIs and history of bladder CA treated by Doctor. Patient will need outpatient Cysto once UTI resolved per Urology. She will also need PCP follow up.   Moderna vaccine and Influenza given at Physicians office.
Symptoms Lasted 12 hours:  Achy Fever 99.5  headache  sensitive to light  cold but felt hot    Took Tylenol to help with symptom
1st shot, Rt. Knee and lower leg suffering pain when walking. 2nd shot, Rt Knee and leg and ankle no longer support body. Having to use walker.
After receiving FLULAVAL 10/06/10, next day facial drooping paralysis. Latex dx 10/10/10 Bell's Palsy on medications now. On meds MEDROL PACK, and VALTREX.
after the shotI saat 15 miuntes. let started haveing trouble with mt throat . it started to close ! I went back to where I got the shot, they hit me with an Epic pen and they called 911. I felted as if I was going to pass out . was taken to The ER , they treated me wit three different meds and keep me tere for a few hours ang sent me home with meds to take . theysaid if I should hve any more problems come back. and That I was There first csae like this from the shot.. I was plenty scared.
After receiving third injection of GARDASIL there was an acute pain in lower back. Persistent to this date. Sibling-sister-has same acute symptom. Diagnosed as sciatica but not convinced due to the events for two sisters with same symptoms. 7/31/08-records received for DOS 6/25/07-emotional problems, lower back leg pain, sciatica. HPV#1 received 4/9/07, HPV#2 6/4/07, vaccine administration GYN office. Office visit 7/9/07-still C/O back pain getting worse. 12/28/07-hives and itching for 2 months, urticaria. 3/21/08-C/O back pain on and off last seen for this complaint was 7/9/07.
Fully vaccinated and boosted 11/18/21.  COVID infection breakthrough with inpatient hospital stay.  Underlying chronic lung disease.
This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised). At the time of the report, IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. Moderna vaccine was ordered on 01-Nov-2021 and 15-Nov-2021. The beyond use date of the vaccine was reported as 01-Dec-2021 to 15-Dec-2021. The reporter reported that they had a group of 13 pharmacies that had administered the Moderna vaccine. Their digital data loggers and freezers expired before they were re-calibrated. They were aware that in some of the freezers there was a temperature excursion that their data logs showed. They wanted to reach out to see if the vaccines had been compromised. The vaccines had never reached a temperature that was considered outside of frozen recommended range. The data loggers had laps where they were not considered calibrated, so they had paper logs to monitor those temperatures. The reporter asked whether they need to take any action in relation to the doses administered since the vaccines were stored in an unapproved freezer without a digital data logger. This was in several different freezers and the vial temperatures never went out of range when they were using the paper log. No treatment information was provided.
Pt reports continued left arm pain at site of modern covid vaccine.  Reports left deltoid developed pain at site the day of vaccination on 1/27/22.  Reports pain has never resolved.  Also reports increased hair loss following covid vaccine on 1/27/22.  reports mild hair loss prior to vaccine.
mom reports stridor, lips swollen p/given 2 1/2oz Simulac w/Fe firs time today;has only been breastfeeding-amb called 02 given to hosp ER;
suspected vaccination failure/had shingles twice since I've had the 2 shots; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (have had shingles before having the shingles vaccine).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient have had shingles before he/she received the shot and twice since he/she had the 2 shots. The patient was hoping to not get them again. The patient reported that the doctor could give the medication to help. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.
Within 5 minutes of injection patient felt hot, felt like she was going to be short of breath, blurred vision, saw "white", turned red, low back pain.  Provider called the emergency dept. for advice, was advised to monitor. Provider and CMA attended to patient by taking vitals, monitoring, and within 5 minutes symptoms started to subside. Patient remained at clinic for approximately 40 minutes under supervision and felt fine upon leaving, was advised not to drive, patient's husband transported home.
The Rash is described as flat and darkened. It began 4 days ago. The Rash is located left deltoid area. It occurs as an acute condition. The Rash is associated with mild pain with deep palpation, states it is really not bothering her; it is not associated with itch, myalgias/arthralgias or burning/stinging. states she first noticed it about 24 hours after getting shingrix. She had muscle tenderness for the first 24 hours and applied ice for about 20 minutes at a time several time the first 24 hours. States soreness went away and she first noticed the skin discoloration on night of 5/31.
pt recv vax 20SEP95 & 3OCT95 pt devel hives all over body;no further details were provided;
Even after the 2nd shot, I still have remnants of sore bumps; Even after the 2nd shot, I still have remnants of sore bumps; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on unknown date and refer case id US2021AMR093225).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and local swelling. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain and local swelling were unknown.   It was unknown if the reporter considered the pain and local swelling to be related to Shingles vaccine.  Additional details were provided as follow: The case was reported by the consumer itself. The age at vaccination was not applicable for this report. The patient received 2nd dose of shingles vaccine on an unknown date. The patient experienced same events pain and local swelling. No further information was provided.
Throat tightening on 1/14/10, hives appeared 1/15/10, resolving as of 1/19/10. Treated herself with BENADRYL.
POTENTIAL ADMINISTRATION ERROR (ADMINISTRATION OF AN EXPIRED VACCINE); OFF LABEL USE; TEMPERATURE EXCURSION; This spontaneous report received from a physician concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: 23-JUN-2021) dose was not reported, administered on 07-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-JUN-2021, the subject experienced potential administration error (administration of an expired vaccine). On 07-JUN-2021, the subject experienced off label use. On 07-JUN-2021, the subject experienced temperature excursion. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from potential administration error (administration of an expired vaccine), and the outcome of off label use and temperature excursion was not reported. This report was non-serious. This case, from the same reporter is linked to 20210616952 and 20210617020.
pt began screaming for 1 1/2 hrs; 1/2 hrs a/arrived in ER, pt turned blue around eyes, nose, face began jerking; had vomited, t99.1 R @ home; rt TM ? red; crying intermittently;
Patient stated feeling lightheaded and tingling sensation on left leg after receiving second dose of Pfizer Covid vaccine. Client was sitting on waiting area post vaccine for 15 minutes. EMT responded and alerted lead RN. Vitals taken at 1310: blood pressure 116/82, pulse 72, oxygen 99. Alert and oriented, stated symptoms began after vaccine. No prior history of tingling sensation in extremities. Stated tingling on left leg, mobility intact, no radiation or pain past leg. Allergies to amoxicillin and no current medications. Client given water and instructed to drink small sips. Per client no breakfast this morning and had two cups of coffee. Client denied chest pain, shortness of breath, palpitations, vision changes, headache. RN client asked to stay under observation longer and that EMT would recheck vitals prior to her leaving. EMT reassessed at 1325. Per client feeling better, was returning to work after leaving facility. Instructed to get food and rest. Last set of vitals: blood pressure 120/80, pulse 62, oxygen 99. Client left facility with a steady gait.
Heavy fatigue starting 4 hours after vaccine and lasting about 8 hours; This is a spontaneous report from a non-contactable consumer (patient herself). A 43-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6200, expiration date was not reported), via an unspecified route of administration, administered in left arm on 18Feb2021 (age at vaccination; 43-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. After 4 hours of vaccination on 18Feb2021, the patient had experienced heavy fatigue which lasted for about 8 hours. The patient received treatment for the event. The outcome of the event was recovered.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
Itch at injection site; Significant red area at the injection site; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itch at injection site), VACCINATION SITE ERYTHEMA (Significant red area at the injection site) and INJECTION SITE RASH (Rash at injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itch at injection site), VACCINATION SITE ERYTHEMA (Significant red area at the injection site) and INJECTION SITE RASH (Rash at injection site). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itch at injection site), VACCINATION SITE ERYTHEMA (Significant red area at the injection site) and INJECTION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jan-2021: Additional information updates. Patient initials added. Patient demographics were added. Added treatment medications. Added New events.
mild fever started 15JUN98 followed by tiny papular lesions over trunk, mild h/a w/mild sore throat, gen malaise & irritated eyes;no fever when seen on 18JUN98;